Medicated Skin Care in China

Publication Date	September 2009
Publisher	Euromonitor
Product Type	Report
Pages	51
ISBN Number	not applicable
Product Code	EUR00623

Buy this product or for assistance call +44 20 7060 7474

PDF £560.00$932 | €627

FAX Order above formats by FAX

Summary

Euromonitor International's Medicated Skin Care in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage:

acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage:

market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

Get a detailed picture of the medicated skin care industry
Identify factors driving change
Understand the competitive environment, the market's major players and leading brands
Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning

Content

Medicated Skin Care in China
Euromonitor International
September 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
- Table 1 Sales of Medicated Skin Care by Subsector: Value 2003-2008
- Table 2 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
- Table 3 Herbal vs Standard Medicated Skin Care 2003-2008
- Table 4 Acne Treatments by Format: % Value Breakdown 2004-2008
- Table 5 Medicated Skin Care Company Shares by Value 2004-2008
- Table 6 Medicated Skin Care Brand Shares by Value 2005-2008
- Table 7 Acne Treatments Brand Shares by Value 2005-2008
- Table 8 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
- Table 9 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
Amway (china) Co Ltd
Strategic Direction
Key Facts
- Summary 1 Amway (China) Co Ltd: Key Facts
Company Background
Production
Competitive Positioning
- Summary 2 Amway (China) Co Ltd: Competitive Position 2008
Bristol-Myers Squibb (shanghai) Trading Co Ltd
Strategic Direction
Key Facts
- Summary 3 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Key Facts
Company Background
Production
- Summary 4 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Production Statistics 2008
Competitive Positioning
- Summary 5 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Competitive Position 2008
GlaxoSmithKline (tianjin) Pharm Co Ltd
Strategic Direction
Key Facts
- Summary 6 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Key Facts
Company Background
Production
- Summary 7 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Production Statistics 2008
Competitive Positioning
- Summary 8 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Competitive Position 2008
Jiangzhong Pharmaceutical Co
Strategic Direction
Key Facts
- Summary 9 Jiangzhong Pharmaceutical Co Ltd: Key Facts
Company Background
Production
Competitive Positioning
- Summary 10 Jiangzhong Pharmaceutical Co Ltd: Competitive Position 2008
Sanjiu Enterprise Group
Strategic Direction
Key Facts
- Summary 11 Sanjiu Enterprise Group: Key Facts
Company Background
Production
Competitive Positioning
- Summary 12 Sanjiu Enterprise Group: Competitive Position 2008
Tianjin Tianshi Biological Development Co Ltd
Strategic Direction
Key Facts
- Summary 13 Tianjin Tianshi Biological Development Co Ltd: Key Facts
Company Background
Production
Competitive Positioning
- Summary 14 Tianjin Tianshi Biological Development Co Ltd: Competitive Position 2008
Tibet Linzhi Qizheng Tibetan Medicine Fty
Strategic Direction
Key Facts
- Summary 15 Tibet Linzhi Qizheng Tibetan Medicine Fty: Key Facts
Company Background
Production
- Summary 16 Tibet Linzhi Qizheng Tibetan Medicine Fty: Production Statistics 2007
Competitive Positioning
- Summary 17 Tibet Linzhi Qizheng Tibetan Medicine Fty: Competitive Position 2008
Wyeth Pharmaceutical Co Ltd
Strategic Direction
Key Facts
- Summary 18 Wyeth Pharmaceutical Co Ltd: Key Facts
Company Background
Production
- Summary 19 Wyeth Pharmaceutical Co Ltd: Production Statistics 2008
Competitive Positioning
- Summary 20 Wyeth Pharmaceutical Co Ltd: Competitive Position 2008
Xian Janssen Pharmaceutical Ltd
Strategic Direction
Key Facts
- Summary 21 Xian Janssen Pharmaceutical Ltd: Key Facts
Company Background
Production
Competitive Positioning
- Summary 22 Xian Janssen Pharmaceutical Ltd: Competitive Position 2008
Yunnan Baiyao Group Co Ltd
Strategic Direction
Key Facts
- Summary 23 Yunnan Baiyao Group Co Ltd: Key Facts
Company Background
Production
- Summary 24 Yunnan Baiyao Group Co Ltd: Production Statistics 2008
Competitive Positioning
- Summary 25 Yunnan Baiyao Group Co Ltd: Competitive Position 2008
Executive Summary
Growing Health Awareness and Disposable Incomes Fuel Growth
Vitamins and Dietary Supplements Lead Growth
Amway Leads Fragmented OTC Healthcare
Chemists/pharmacies Lead But Direct Selling Grows Fastest
Steady Growth for Forecast Period
Key Trends and Developments
Rising Health-consciousness and Self-medication
Convenience Becomes Increasingly Important
Lifestyle Changes Shape Growth
Players Increasingly Focus on Specific Consumer Targets
Deep-rooted Tradition Impacts OTC Healthcare
Territory Key Trends and Developments
East China
Mid China
North and Northeast China
Northwest China
South China
Southwest China
Market Indicators
- Table 10 Consumer Expenditure on Health Goods and Medical Services 2003-2008
- Table 11 Life Expectancy at Birth 2003-2008
Market Data
- Table 12 Sales of OTC Healthcare by Sector: Value 2003-2008
- Table 13 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
- Table 14 Sales of OTC Healthcare by Region: Value 2003-2008
- Table 15 Sales of OTC Healthcare by Region: % Value Growth 2003-2008
- Table 16 OTC Healthcare Company Shares by Value 2004-2008
- Table 17 OTC Healthcare Brand Shares by Value 2005-2008
- Table 18 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
- Table 19 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
- Table 20 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
- Table 21 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
- Table 22 Forecast Sales of OTC Healthcare by Region: Value 2008-2013
- Table 23 Forecast Sales of OTC Healthcare by Region: % Value Growth 2008-2013
- Appendix
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
- Summary 26 OTC Healthcare Switches 2005-2007
Definitions
- Summary 27 Research Sources